Unlocking the Future of the Injectable Drug Delivery Devices Market: Growth Rate, Key Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the injectable drug delivery devices market right now?
In the past few years, the market for injectable drug delivery devices has seen significant growth, expanding from $49.59 billion in 2024 to an anticipated $54.67 billion in 2025. This represents a compound annual growth rate (CAGR) of 10.3%. Factors contributing to this growth during the historic period include a rapid increase in the elderly population, the expansion of healthcare facilities, a rise in healthcare spending, growth in biologics, and a heightened awareness of self-administration.
How fast Is the injectable drug delivery devices market expected to grow, and what’s its future value?
The projected expansion of the hospitality market size is impressive for the upcoming years, anticipated to increase to $7239.02 billion by 2029 with a compound annual growth rate (CAGR) of 6.1%. Factors contributing to the anticipated growth during this period include sustainability initiatives, wellness tourism, flexibility in booking, partnerships with local communities, and adherence to health and safety norms. Key trends to watch during this forecast period encompass customization and artificial intelligence, touchless technologies, advances in technology, tailor-made guest experiences, digital promotions, and the impact of social media.
Get your injectable drug delivery devices market report here!
What are the leading drivers of growth in the injectable drug delivery devices market?
The rise in popularity of devices for self-injection is propelling the market for injectable drug delivery devices. Self-injection devices are medical instruments that enable patients to administer medication themselves at home. These devices range from needle-free to auto, pen, and wearable injectors. They were invented to be the most versatile gadget delivering drugs with high accuracy and simple operation. Furthermore, advances in self-injectable devices have led to greater acceptance of these products in recent years. BD Physioject, a disposable auto-injector produced by Becton, Dickinson, and Company, is clinically verified, trustworthy, cost-effective, and designed specifically for self-injection by individuals with chronic illnesses such as rheumatoid arthritis, multiple sclerosis, asthma, and osteoporosis. Other companies engaged in the self-injection market include AbbVie, Inc., 3M, Baxter, Gerresheimer AG, Pfizer Inc., and others. The benefits of self-administered injections and increasing awareness of self-treatment have amplified the demand for self-injеctablе devices, which will continue to stimulate the injectable drug delivery devices market in the forecast period.
What are the key segments defining the injectable drug delivery devices market?
The injectable drug delivery devices market covered in this report is segmented –
1) By Type: Syringes, Injectors And Pump
2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users
Subsegments:
1) By Syringes: Conventional Syringes, Prefilled Syringes, Safety Syringes
2) By Injectors: Autoinjectors, Pen Injectors, Needle-Free Injectors
3) By Pumps: Insulin Pumps, Ambulatory Infusion Pumps, Implantable Pumps
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp
Who are the key players steering the development of the injectable drug delivery devices market?
Major companies operating in the injectable drug delivery devices market include Becton, Dickinson and Company, Baxter International, Gerresheimer AG, Catalent, Inc., SkyePharma PLC, Antares Pharma, Pfizer Inc, GE Healthcare, Owen Mumford, Catalent Pharma Solutions, Philips, West Pharmaceutical Services, Inc., Alkermes, Schott AG, UCB, AstraZeneca, Johnson & Johnson, NEARMEDIC PLUS LLC, Pendant Biosciences, Siemens, H&T Presspart, B Braun, Copernicus, Ypsomed AG, 3M Company, Aptar, Congenica Ltd., Julphar, Nemera, Stryker, Roche, Nektar Therapeutics, Eli Lilly, Merck & Co. Inc., Sandoz, Sorrel Medical, Teleflex Medical, Gilero, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, MediPrint Ophthalmics, Medtronic, Novartis, Pharmasyntez, Bayer, Mylan N.V, Aptalis Pharma, Inc., Sanofi, Novo Nordisk, Bilim Pharmaceuticals, Battelle Medical Devices, Caplin Steriles Limited, Abbot, Allergan, Boehringer Ingelheim, Hovione Technology, Jiangsu Delfu Medical Device Co, Ltd., Syqe Medical, Terumo Corporation, Kedalion Therapeutics, Amgen Inc.
What emerging trends are influencing the growth of the injectable drug delivery devices market?
There has been a notable increase in focus on auto-injectors’ production by companies that manufacture injectable drug delivery devices. Auto-injectors are entirely automated, customizable, and reusable, capable of being used by patients to carry out hundreds of injections. They allow patients to regulate the speed at which the dose is delivered, thus reducing pain or discomfort. These devices also allow adjustments to the speed and depth of automatic shots. An example is the LISA auto-injector by Unilife Corporation, furnished with a variety of customizable features such as Bluetooth LE, Wi-Fi or 3G connectivity, and pre-injection drug warming for specific therapies. Significant growth is anticipated in the injectable drug delivery technology market due to advancements in technology and the introduction of new products aimed at simplifying the administration of parental therapeutics.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2835
Which regions are most influential in expanding the injectable drug delivery devices market?
North America was the largest region in the injectable drug delivery devices market in 2024. Western Europe was the second-largest region in the global injectable drug delivery devices market. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Drugs For Hormonal Replacement Therapy Global Market Report 2024
Drugs for Immunotherapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report
Medical Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
